SheerVision Inc
SheerVision, Inc. designs, develops, and manufactures loupe and headlight systems for surgical, dental, dental hygiene, and veterinary markets. Its products include flip-up, through the lens, V-RAY, infinity ultra2, ultra mini surgical headlights, and dental headlights. The company sells its products through distributors and e-commerce Website. SheerVision, Inc. was founded in 1999 and is based i… Read more
SheerVision Inc (SVSO) - Net Assets
Latest net assets as of May 2010: $-876.76K USD
Based on the latest financial reports, SheerVision Inc (SVSO) has net assets worth $-876.76K USD as of May 2010.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($781.58K) and total liabilities ($1.66 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-876.76K |
| % of Total Assets | -112.18% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 957.11 |
SheerVision Inc - Net Assets Trend (2000–2009)
This chart illustrates how SheerVision Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for SheerVision Inc (2000–2009)
The table below shows the annual net assets of SheerVision Inc from 2000 to 2009.
| Year | Net Assets | Change |
|---|---|---|
| 2009-08-31 | $-593.84K | -126.74% |
| 2008-08-31 | $-261.90K | -347.89% |
| 2007-08-31 | $105.65K | -91.75% |
| 2006-08-31 | $1.28 Million | +4607.18% |
| 2005-08-31 | $-28.40K | -2284.46% |
| 2004-08-31 | $1.30K | +105.37% |
| 2003-08-31 | $633.00 | -79.74% |
| 2002-08-31 | $3.12K | +1185.60% |
| 2001-08-31 | $243.00 | -90.10% |
| 2000-08-31 | $2.46K | -- |
Equity Component Analysis
This analysis shows how different components contribute to SheerVision Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 477995500.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (August 2009)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $12.76K | % |
| Other Components | $4.99 Million | % |
| Total Equity | $-593.84K | 100.00% |
SheerVision Inc Competitors by Market Cap
The table below lists competitors of SheerVision Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
China Clean Energy
PINK:CCGY
|
$0.92 |
|
Radium Resources Corp
PINK:RADR
|
$0.92 |
|
Ubiquitech Software
PINK:UBQU
|
$0.92 |
|
Phosphate Holdings Inc
PINK:PHOS
|
$0.92 |
|
PacificHealth Laboratories Inc
PINK:PHLI
|
$0.92 |
|
USCorp
PINK:USCS
|
$0.92 |
|
ComF5 International Inc
PINK:CMFV
|
$0.92 |
|
Ijj Corporation
PINK:IJJP
|
$0.92 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in SheerVision Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2008 to 2009, total equity changed from -261,904 to -593,838, a change of -331,934.
- Net loss of 71,376 reduced equity.
- Other factors decreased equity by 260,558.
Equity Change Factors (2008 to 2009)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-71.38K | -12.02% |
| Other Changes | $-260.56K | -43.88% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares SheerVision Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2000-08-31 | $0.00 | $0.00 | x |
| 2001-08-31 | $0.00 | $0.00 | x |
| 2002-08-31 | $0.00 | $0.00 | x |
| 2003-08-31 | $0.00 | $0.00 | x |
| 2004-08-31 | $0.00 | $0.00 | x |
| 2005-08-31 | $-0.03 | $0.00 | x |
| 2006-08-31 | $0.25 | $0.00 | x |
| 2007-08-31 | $0.01 | $0.00 | x |
| 2008-08-31 | $-0.02 | $0.00 | x |
| 2009-08-31 | $-0.05 | $0.00 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently SheerVision Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2.04%
- • Asset Turnover: 4.18x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-2924.40%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2000 | -512.87% | -629550.00% | 0.00x | 10.16x | $-12.84K |
| 2001 | -7083.13% | -1721200.00% | 0.00x | 142.77x | $-17.24K |
| 2002 | -964.53% | -602.64% | 0.17x | 9.51x | $-30.44K |
| 2003 | -13821.64% | -1458.18% | 0.27x | 34.74x | $-87.55K |
| 2004 | -5821.38% | -1051.08% | 0.26x | 21.57x | $-75.81K |
| 2005 | 0.00% | 0.00% | 0.00x | 0.00x | $-76.86K |
| 2006 | -183.55% | -78.82% | 1.81x | 1.28x | $-2.48 Million |
| 2007 | -856.86% | -20.80% | 5.08x | 8.10x | $-915.85K |
| 2008 | 0.00% | -5.06% | 4.60x | 0.00x | $-197.42K |
| 2009 | 0.00% | -2.04% | 4.18x | 0.00x | $-11.99K |
Industry Comparison
This section compares SheerVision Inc's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $2,683,526,542
- Average return on equity (ROE) among peers: -32.48%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| SheerVision Inc (SVSO) | $-876.76K | -512.87% | N/A | $0.92 |
| ANGELALIGN TECHNOLOGY INC (AGLFF) | $480.24 Million | 2.52% | 0.41x | $405.57 Million |
| Akoya Biosciences Inc (AKYA) | $-30.16 Million | 0.00% | 0.00x | $16.24 Million |
| Alcon AG (ALC) | $19.68 Billion | 1.70% | 0.48x | $37.82 Billion |
| Align Technology Inc (ALGN) | $3.85 Billion | 10.94% | 0.61x | $11.75 Billion |
| AngioDynamics Inc (ANGO) | $355.71 Million | 3.06% | 0.15x | $354.40 Million |
| Ansell Limited (ANSLF) | $386.33 Million | -0.45% | 0.87x | $2.58 Billion |
| AptarGroup Inc (ATR) | $2.07 Billion | 11.57% | 1.03x | $8.27 Billion |
| AtriCure Inc (ATRC) | $72.60 Million | -15.79% | 0.54x | $1.42 Billion |
| Avinger Inc (AVGR) | $-35.69 Million | 0.00% | 0.00x | $1.26 Million |
| Anteris Technologies Global Corp. Common Stock (AVR) | $9.03 Million | -338.35% | 0.77x | $156.14 Million |